Amerikanische Gesellschaft für Hirudotherapie

Preventing infective complications following leech therapy: elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana using antibiotic feeding

Microbiology study published in Surgical Infections (2014)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSicherheit & InfektionskontrolleKlinische StudienLitwinowicz A, Blaszkowska J · Surgical Infections, 2014

Abstract

BACKGROUND: Hirudotherapy is often used successfully in modern medicine, especially in plastic and reconstructive surgery. However, Aeromonas infections are the most common complications of post-operative leech application. Hence, prophylactic antibiotic administration is recommended before and during leech therapy. It has been confirmed that patient safety and achieving the desired therapeutic effect depend mainly on the microbiologic purity of the animals used. The aims of this study were to find a safe and practical way to eradicate symbiotic Aeromonas spp. occuring in the intestine of Hirudo verbana. METHODS: Leeches were fed artificially with 1.5 mL of sterile defibrinated sheep blood supplemented with ciprofloxacin (CIP) or cefotaxime (CTX), at bacteriostatic concentrations of 0.2 mcg/mL or 1.5 mcg/mL, and bactericidal concentrations of 20 mcg/mL or 50 mcg/mL, respectively. Bacteria were isolated from the leech intestines before and after feeding at different time intervals: 1, 7, 14, 21, and 28 d. RESULTS: Biochemical identification of bacterial isolates from water samples and intestines of H. verbana using the API-NE20 test showed that A. veronii biovar sobria was predominant. Bacteria belonging to the genus Aeromonas were detected in all control leeches. The results showed that optimum eradication of bacteria from leech intestines was obtained using 20 mcg/mL of CIP and 50 mcg/mL of CTX, which decreased the number of Aeromonas spp. to undetectable levels for two weeks after feeding in all treated leeches. A statistically significant reduction in the number of bacterial colonies (p<0.0001) was observed in leeches treated with bacteriostatic concentrations of CIP or CTX; no bacterial growth was found on the plates after only seven days of feeding with antibiotics. All water samples in which the leeches were kept before treatment were contaminated with Aeromonas spp., whereas these samples were negative after antibiotic feeding of animals. CONCLUSIONS: All leeches were ready to take a blood meal after treatment, suggesting the possibility of using ciprofloxacin-treated or cefotaxime-treated leeches instead of chemoprophylaxis in patients undergoing hirudotherapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAeromonasAnimal FeedAnimalsAnti-Bacterial AgentsDietGram-Negative Bacterial InfectionsHumansIntestinesLeechesLeeching

Zusammenfassung

Feeding Hirudo verbana sheep blood supplemented with ciprofloxacin (20 µg/mL) or cefotaxime (50 µg/mL) eradicated symbiotic Aeromonas veronii biovar sobria from leech gut for two weeks — supports antibiotic-fed leech application as alternative to patient chemoprophylaxis.

Warum dies für die Hirudotherapie relevant ist

This study investigated whether feeding Hirudo verbana leeches with defibrinated sheep blood supplemented with antibiotics (ciprofloxacin or cefotaxime) could eradicate symbiotic Aeromonas spp. from their intestines, addressing the most common infectious complication of hirudotherapy. Bactericidal concentrations (20 mcg/mL ciprofloxacin or 50 mcg/mL cefotaxime) reduced Aeromonas to undetectable levels for two weeks post-feeding, all treated leeches subsequently accepted blood meals, and holding water tested negative for Aeromonas after treatment. This research is highly relevant to ASH's domain, directly tackling a major safety barrier to wider hirudotherapy adoption by proposing a method to produce microbiologically clean leeches that could reduce or eliminate the need for patient antibiotic prophylaxis. Caveat: While promising, this is a preclinical laboratory study; the abstract does not report data from actual patient application of treated leeches, and clinical validation of safety and efficacy in humans would be needed before adoption.

Zitation

Preventing infective complications following leech therapy: elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana using antibiotic feeding.

Litwinowicz A, Blaszkowska J · Surgical Infections, 2014

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.